• Small Molecules
      • Discovery
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers


Syngene has considerable experience in peptide development including state-of-the-art analytical instruments for peptide purification and characterization. Our experience in Peptide development is as follows:

  • Linear peptides:  Up to 50 residues, up to g scale, purity > 95%;
  • Disulfide rich peptides (Linear and Cyclotides)
  • Library of 50 compounds (20-50 mg, >95%)
  • Branched Chain peptides
  • Cyclic peptides: Amides, Lactams, Disulfide bridge, Stapled peptides.
  • N-Terminal and C-Terminal modification
  • Phosphorylated peptides
  • PEG, Fluorescein, Biotin labeled peptides
  • Peptides linked to bifunctional chelating agents such as DOTA, DTPA and AAZTA
  • Ligation: NCL and KAHA ligation

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details